Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2003
03/13/2003US20030050316 An amine compound of phenyl or hetero ring for treating Alzheimer's disease
03/13/2003CA2458527A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003CA2458093A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
03/13/2003CA2453215A1 Sulfonylamino derivatives useful as herbicides
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291343A1 Hydroxyformamidine derivatives and medicines containing the same
03/12/2003EP1291342A1 Pyridinium-betain compounds as taste enhancer
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1291081A1 Process for the preparation of pyrrole and pyridine
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289941A1 Carbamic acid esters as inhibitors of factor xa
03/12/2003EP1289935A1 Excitatory amino acid receptor modulators
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0873325B1 Process for producing guanidine derivatives, intermediates therefor and their production
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402709A 4-pyridinyl-N-acyl-L-phenylalanines
03/12/2003CN1402708A Process for production of pyridine derivs.
03/12/2003CN1401649A Process for preparing dialkylpyridyl borane
03/12/2003CN1401634A 4-guanidinobenzamides antifertility compounds
03/11/2003US6531704 Nanotechnology for engineering the performance of substances
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531606 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
03/11/2003US6531605 Reacting diazonium salt of aminopyridine or aminobenzene with thionyl chloride in water, electron transfer catalyst; 2-chloropyridine-3-sulfonyl chloride; avoids use of acetic acid and sulfur dioxide; no extraction isolation problems
03/11/2003US6531597 Reacting a halo substituted benzene with a ketone to form a hydroxyalkyl benzene that is carbonylated with a strong acid
03/11/2003US6531495 Potassium channel
03/11/2003US6531494 Gem-substituted αvβ3 antagonists
03/11/2003US6531472 Tetralone derivatives
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/11/2003CA2262837C An asymmetric conjugate addition reaction
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019697A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
03/06/2003WO2003018559A2 Intermediates and preparation thereof for the enantioselective synthesis of (20r) homocamptothecins
03/06/2003WO2003018558A1 Environment-sensitive luminescent dimine-platinum binuclear complexes
03/06/2003WO2003018557A1 Hydrazinopeptoids and their uses for treating cancers
03/06/2003WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors
03/06/2003WO2003018543A1 Novel cyclohexyl sulphones
03/06/2003WO2003018536A1 Chemotherapeutic agents
03/06/2003WO2003018515A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
03/06/2003WO2003018059A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003WO2003017955A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
03/06/2003WO2003017948A2 Aryl tetrahydronaphthalene derivatives
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2003000198A3 Selective neuronal nitric oxide synthase inhibitors
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002083662A3 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
03/06/2003WO2002046160A3 Process for making a thrombin inhibitor
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045723 Useful in treatment of a variety of cytokine related disorders including rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, osteoarthritis, neuropathic pain, HIV replication, HIV dementia
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045555 Process to chiral integrin antagonist beta-amino acid intermediate
03/06/2003US20030045519 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/06/2003US20030045515 Cyanoguanidine I kappa B kinase inhibitors as antiproliferative agents for cancer treatment
03/06/2003CA2457974A1 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003CA2457676A1 Chemotherapeutic agents
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/06/2003CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003CA2430267A1 Hydrazinopeptoids and their uses for treating cancers
03/05/2003EP1288217A2 Preparation of dialkylpyridylboranes
03/05/2003EP1286985A1 Substituted pyridine herbicides
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286968A2 Substituted iminoazines
03/05/2003EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1194427B1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
03/05/2003EP1042278B1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
03/05/2003EP1021411B1 Benzamide derivatives as thrombin inhibitors
03/05/2003EP1019368B1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003EP0627433B1 Process for producing imidazopyridine derivative and intermediate
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/04/2003US6528677 Selective retinoid agonists
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528651 Ring cleavage deamination of a triazacylclohexane derivative with hydrogen chloride
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 633